TPTX

Turning Point Therapeutics (TPTX)

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:TPTX
DataOraFonteTitoloSimboloCompagnia
29/08/202222:31Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:TPTXTurning Point Therapeutics Inc
23/08/202212:03Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:TPTXTurning Point Therapeutics Inc
17/08/202222:44Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TPTXTurning Point Therapeutics Inc
17/08/202215:03Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:TPTXTurning Point Therapeutics Inc
17/08/202215:01Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:TPTXTurning Point Therapeutics Inc
17/08/202215:01Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:TPTXTurning Point Therapeutics Inc
17/08/202214:45Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TPTXTurning Point Therapeutics Inc
16/08/202213:11Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:TPTXTurning Point Therapeutics Inc
16/08/202213:09Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:TPTXTurning Point Therapeutics Inc
16/08/202212:59Business WireBristol Myers Squibb and Turning Point Therapeutics Announce Expiration of HSR Act Waiting Period and Clearance from Federal Cartel Office of Germany Related to Pending Acquisition of Turning Point TherapeuticsNASDAQ:TPTXTurning Point Therapeutics Inc
11/08/202205:20TipRanksAnalysts Offer Insights on Healthcare Companies: Reata Pharmaceuticals (RETA), Turning Point Therapeutics (TPTX) and Talkspace (TALK)NASDAQ:TPTXTurning Point Therapeutics Inc
10/08/202206:35TipRanksJMP Securities Remains a Hold on Turning Point Therapeutics (TPTX)NASDAQ:TPTXTurning Point Therapeutics Inc
08/08/202222:20Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:TPTXTurning Point Therapeutics Inc
08/08/202222:17GlobeNewswire Inc.Turning Point Therapeutics Reports Second-Quarter 2022 Financial Results, Provides Operational UpdatesNASDAQ:TPTXTurning Point Therapeutics Inc
01/08/202205:31TipRanksSVB Securities Maintains a Hold Rating on Turning Point Therapeutics (TPTX)NASDAQ:TPTXTurning Point Therapeutics Inc
27/07/202222:05GlobeNewswire Inc.Turning Point Therapeutics Provides Regulatory Update for Repotrectinib for the Treatment of ROS1+ Advanced NSCLCNASDAQ:TPTXTurning Point Therapeutics Inc
24/06/202215:00GlobeNewswire Inc.Turning Point Therapeutics and MD Anderson Announce Strategic Alliance to Advance Precision Cancer TherapiesNASDAQ:TPTXTurning Point Therapeutics Inc
17/06/202222:47Edgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)NASDAQ:TPTXTurning Point Therapeutics Inc
17/06/202222:44Edgar (US Regulatory)Tender Offer Statement by Third Party (sc To-t)NASDAQ:TPTXTurning Point Therapeutics Inc
14/06/202204:05TipRanksAnalysts Offer Insights on Healthcare Companies: CTI BioPharma (CTIC) and Turning Point Therapeutics (TPTX)NASDAQ:TPTXTurning Point Therapeutics Inc
06/06/202213:38TipRanksWhy Are Bristol-Myers & Turning Point Made for Each Other?NASDAQ:TPTXTurning Point Therapeutics Inc
06/06/202206:25TipRanksAnalysts Have Conflicting Sentiments on These Healthcare Companies: Bicycle Therapeutics (BCYC), Turning Point Therapeutics (TPTX) and Globus Medical (GMED)NASDAQ:TPTXTurning Point Therapeutics Inc
03/06/202223:16Edgar (US Regulatory)Written Communication Relating to an Issuer or Third Party (sc To-c)NASDAQ:TPTXTurning Point Therapeutics Inc
03/06/202216:36Dow Jones NewsTurning Point Therapeutics Shares Surge on Bristol Myers DealNASDAQ:TPTXTurning Point Therapeutics Inc
03/06/202215:06Edgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:TPTXTurning Point Therapeutics Inc
03/06/202213:43Dow Jones NewsBristol Myers to Buy Turning Point Therapeutics for $4.1 BillionNASDAQ:TPTXTurning Point Therapeutics Inc
26/05/202222:30GlobeNewswire Inc.Turning Point Therapeutics to Participate in Upcoming Investor ConferencesNASDAQ:TPTXTurning Point Therapeutics Inc
16/05/202214:30GlobeNewswire Inc.Turning Point Therapeutics Announces Appointment of Steve Sabus as Chief Commercial OfficerNASDAQ:TPTXTurning Point Therapeutics Inc
12/05/202206:25TipRanksAnalysts’ Opinions Are Mixed on These Healthcare Stocks: Concert Pharma (CNCE), Clearside Biomedical (CLSD) and Turning Point Therapeutics (TPTX)NASDAQ:TPTXTurning Point Therapeutics Inc
11/05/202214:43TipRanksSVB Securities Thinks Turning Point Therapeutics’ Stock is Going to RecoverNASDAQ:TPTXTurning Point Therapeutics Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:TPTX
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network